Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Boehringer Ingelheim Voluntarily Recalls Certain Lots of Spiriva Handihaler Capsules

September 25, 2013

Boehringer Ingelheim initiates a recall due to the potential for extrinsic foreign particles in the API used to manufacture Spiriva Handihaler (tiotropium bromide inhalation powder) capsules.

Pfizer Applies Integrated Technology for Cell-Line Development of Proprietary Antibodies

September 25, 2013

Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.

First biosimilar mAb approved in Europe

September 13, 2013

Hospira's Inflectra (infliximab), which is a biosimilar to the reference biologic product, Remicade, has been approved by the EC for the treatment of inflammatory conditions.

Mechanical Control with Foam Granulation Well-Suited for Pharmaceutical Manufacturing

September 11, 2013

Foam granulation is much easier to control under mechanical dispersion conditions, which is where most industrial processes operate.

Novartis Making Moves to Increase Biologics Manufacturing Capability

September 11, 2013

Novartis? half-billion dollar investment in a new biologics production plant in Singapore represents a strategic commitment to its growing biologics portfolio.

Mylan Completes Expansion of Vermont Transdermal Patch Facility

September 09, 2013

Mylan completes expansion of its transdermal patch facility in Vermont.

Sanofi and POZEN Sign Commercial Agreement for PA8140/PA32540 Tablets

September 09, 2013

Sanofi and POZEN sign a license agreement for the commercialization of omeprazole and aspirin combination product.

California State Senate Passes Biosimilars Bill

September 06, 2013

Following passage in the California Assembly, the California State Senate passes legislation to specify requirements for dispensing biosimilars.

Merck & Co. Gets FDA Nod to Manufacture Bulk Vaccine at North Carolina Facility

September 05, 2013

Merck & Co gets FDA approval to manufacture bulk varicella at its in Durham, North Carolina for use in chickenpox and shingles vaccines.

Baxter and Coherus Biosciences Collaborate On Biosimilars

September 05, 2013

Baxter and Coherus Biosciences colaborate to develop and commercialize a biosimilar version of etanercept for Europe, Canada, and, Brazil.